Skip to content
About
Close About
Open About
Company
Our Team
Investor
Science
Close Science
Open Science
Metabo-oncology
Drug Conjugation
Angiogenesis
Pipeline
Close Pipeline
Open Pipeline
Clinical trials
Patients
Media
Close Media
Open Media
SynDevRx Publications
Press Releases and Events
Other Related
Contact us
SDX at AACR: Obesity confers immuno-suppressive tumor microenvironment – Poster Presentation
April 1, 8:00 AM to 12:00 PM
1226 / 4 – A novel polymer-conjugated methionine aminopeptidase 2 (MetAP2) inhibitor SDX-7320 inhibits the growth of EO771 mammary gland tumors and ameliorates the immunosuppressive tumor immune micro-environment (TIME)
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.